Drage koleginice i kolege,
Predstavljanje Naučnog programa 9. Kongresa farmaceuta Srbije sa međunarodnim učešćem se nastavlja! Ovog puta u fokus stavljamo naše najmlađe pacijente kroz najavu za Sesiju 13.
Lekovi po meri najmlađih pacijenata: unapređenje terapije kroz personalizaciju
Primena lekova u pedijatriji nosi jedinstvene izazove zbog velikih razlika između starosnih grupa, ograničenih kliničkih dokaza i specifičnih potreba dece. Kako bi se obezbedila fleksibilnost i preciznost doziranja, neophodan je prelazak na personalizovani pristup lečenju. Tokom ove sesije, učesnici će se upoznati sa strategijama terapije urođenih bolesti metabolizma i kardiometaboličkim posledicama gojaznosti u detinjstvu. Pored toga, naši predavači će govoriti o naprednim pristupima poput model-informisanog doziranja i razvoja inovativnih formulacija koje znatno poboljšavaju prihvatljivost lekova, adherencu i ishode lečenja kod dece.
Detaljnije informacije o programu sesije i tačnu satnicu možete pogledati u objavi ispod!
Dear colleagues,
We continue presenting the Scientific program of the 9th Serbian Congress of Pharmacy with International Participation! This time, our focus is on our youngest patients as we announce Session 13.
Tailoring medicines for children: Enhancing medication through personalization
Paediatric pharmacotherapy presents unique challenges due to variability among patient subgroups, limited clinical evidence, and the specific needs of children. To ensure flexible and accurate dosing, a shift toward personalized medicine is essential. During this session, you will learn about personalized treatment strategies for inborn errors of metabolism and the cardiometabolic consequences of childhood obesity. Furthermore, our speakers will discuss advances in model-informed dosing and innovative formulation designs aimed at improving medication acceptability, adherence, and overall health outcomes in paediatric patients.
Detailed information about the session programme and the exact schedule can be found in the post below!
